TrialMenopause (New York, N.Y.)2020

17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial.

Andrew M Kaunitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.